S
Shiliang Zhang
Researcher at National Institute on Drug Abuse
Publications - 32
Citations - 2532
Shiliang Zhang is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Ventral tegmental area & Glutamate receptor. The author has an hindex of 17, co-authored 26 publications receiving 1770 citations.
Papers
More filters
Journal ArticleDOI
Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model.
Peisu Zhang,Yuki Kishimoto,Ioannis Grammatikakis,Kamalvishnu P. Gottimukkala,Roy G. Cutler,Shiliang Zhang,Kotb Abdelmohsen,Vilhelm A. Bohr,Jyoti Misra Sen,Jyoti Misra Sen,Myriam Gorospe,Mark P. Mattson,Mark P. Mattson +12 more
TL;DR: A role for Aβ-induced OPC cell senescence in neuroinflammation and cognitive deficits in AD is suggested, and a potential therapeutic benefit of senolytic treatments is suggested.
Journal ArticleDOI
Single rodent mesohabenular axons release glutamate and GABA
David H. Root,Carlos A. Mejias-Aponte,Shiliang Zhang,Hui-Ling Wang,Alexander F. Hoffman,Carl R. Lupica,Marisela Morales +6 more
TL;DR: An unanticipated type of VTA neuron is revealed that cotransmits glutamate and GABA and provides the majority of mesohabenular inputs in LHb neurons.
Journal ArticleDOI
Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons
Shiliang Zhang,Jia Qi,Xueping Li,Hui-Ling Wang,Jonathan P. Britt,Alexander F. Hoffman,Antonello Bonci,Carl R. Lupica,Marisela Morales +8 more
TL;DR: A complex type of signaling by mesoaccumbens fibers is revealed in which dopamine and glutamate can be released from the same axons, but are not normally released at the same site or from theSame synaptic vesicles.
Journal ArticleDOI
VTA glutamatergic inputs to nucleus accumbens drive aversion by acting on GABAergic interneurons
Jia Qi,Shiliang Zhang,Hui-Ling Wang,David J. Barker,Jorge Miranda-Barrientos,Marisela Morales +5 more
TL;DR: The ventral tegmental area (VTA) is best known for its dopamine neurons, some of which project to nucleus accumbens (nAcc), but the VTA also has glutamatergic neurons that project to nAcc, and the mesoaccumbens glutamatorgic pathways are reported on, which are the first glutamaters to be shown to mediate aversion instead of reward.
Journal ArticleDOI
A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons.
Jia Qi,Shiliang Zhang,Hui-Ling Wang,Huikun Wang,Jose de Jesus Aceves Buendia,Alexander F. Hoffman,Carl R. Lupica,Rebecca P. Seal,Marisela Morales +8 more
TL;DR: Findings indicate that the DR-VGluT3 pathway to VTA utilizes glutamate as a neurotransmitter and is a substrate linking the DR—one of the most sensitive reward sites in the brain—to VTA dopaminergic neurons.